Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumiracoxib versus celecoxib in primary osteoarthritis
2004-001132-23Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lumiracoxib and celecoxib in osteoarthritis (OA) (3 arms), sponsored by Novartis. Started Mar 2007; status: completed.
02
Drugs
lumiracoxibcelecoxib
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on 2004-001132-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001132-23.